195 related articles for article (PubMed ID: 16826556)
1. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
Xu DW; Wan P; Xia Q
World J Gastroenterol; 2016 Mar; 22(12):3325-34. PubMed ID: 27022214
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant.
Wu X; Kwong A; Heller M; Lokken RP; Fidelman N; Mehta N
Liver Transpl; 2024 Feb; 30(2):151-159. PubMed ID: 37639286
[TBL] [Abstract][Full Text] [Related]
4. Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma.
Yilma M; Mehta N
Surg Oncol Clin N Am; 2024 Jan; 33(1):133-142. PubMed ID: 37945139
[TBL] [Abstract][Full Text] [Related]
5. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
7. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.
Raoul JL; Sangro B; Forner A; Mazzaferro V; Piscaglia F; Bolondi L; Lencioni R
Cancer Treat Rev; 2011 May; 37(3):212-20. PubMed ID: 20724077
[TBL] [Abstract][Full Text] [Related]
8. AASLD guidelines for the treatment of hepatocellular carcinoma.
Heimbach JK; Kulik LM; Finn RS; Sirlin CB; Abecassis MM; Roberts LR; Zhu AX; Murad MH; Marrero JA
Hepatology; 2018 Jan; 67(1):358-380. PubMed ID: 28130846
[No Abstract] [Full Text] [Related]
9. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.
Mazzaferro V; Llovet JM; Miceli R; Bhoori S; Schiavo M; Mariani L; Camerini T; Roayaie S; Schwartz ME; Grazi GL; Adam R; Neuhaus P; Salizzoni M; Bruix J; Forner A; De Carlis L; Cillo U; Burroughs AK; Troisi R; Rossi M; Gerunda GE; Lerut J; Belghiti J; Boin I; Gugenheim J; Rochling F; Van Hoek B; Majno P;
Lancet Oncol; 2009 Jan; 10(1):35-43. PubMed ID: 19058754
[TBL] [Abstract][Full Text] [Related]
10. Changes in the Liver Transplant Waiting List after Expanding to the 'Up-to-Seven' Criteria for Hepatocellular Carcinoma.
Zamora-Olaya JM; Aparicio-Serrano A; Amado Torres V; Poyato González A; Montero JL; Barrera Baena P; Sánchez Frías M; Ciria Bru R; Briceño Delgado J; De la Mata M; Rodríguez-Perálvarez M
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138897
[TBL] [Abstract][Full Text] [Related]
11. [Individualized curative treatment for malignant diseases through liver transplantation].
Schwenk L; Rauchfuß F; Ali-Deeb A; Dondorf F; Rohland O; Ardelt M; Settmacher U
Chirurgie (Heidelb); 2024 Feb; 95(2):122-128. PubMed ID: 37847311
[TBL] [Abstract][Full Text] [Related]
12. Insights into the history and tendency of liver transplantation for liver cancer: a bibliometric-based visual analysis.
He X; Xu S; Tang L; Ling S; Wei X; Xu X
Int J Surg; 2024 Jan; 110(1):406-418. PubMed ID: 37800536
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study.
Huo H; Wang X; Xu S; Niu X; Cheng L; Yuan Z; Huo S; Fang P
Oncol Lett; 2023 Nov; 26(5):465. PubMed ID: 37780547
[TBL] [Abstract][Full Text] [Related]
14. Downstaging hepatocellular carcinoma before liver transplantation: A multicenter analysis of the "all-comers" protocol in the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) consortium.
Natarajan B; Tabrizian P; Hoteit M; Frenette C; Parikh N; Ghaziani T; Dhanasekaran R; Guy J; Shui A; Florman S; Yao FY; Mehta N
Am J Transplant; 2023 Nov; 23(11):1771-1780. PubMed ID: 37532179
[TBL] [Abstract][Full Text] [Related]
15. Optimal treatment for small HCC (<3 cm): Resection, liver transplantation, or locoregional therapy?
Wu X; Lokken RP; Mehta N
JHEP Rep; 2023 Aug; 5(8):100781. PubMed ID: 37456674
[TBL] [Abstract][Full Text] [Related]
16. Growing need of adjuvant therapy and expanded access for liver transplant in hepatocellular carcinoma.
Mukthinuthalapati VVPK; Gupta S
Ann Transl Med; 2023 Jan; 11(2):32. PubMed ID: 36819559
[No Abstract] [Full Text] [Related]
17. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation.
Minoux K; Lassailly G; Ningarhari M; Lubret H; El Amrani M; Canva V; Truant S; Mathurin P; Louvet A; Lebuffe G; Goria O; Nguyen-Khac E; Boleslawski E; Dharancy S
Transpl Int; 2022; 35():10569. PubMed ID: 36438781
[TBL] [Abstract][Full Text] [Related]
18. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes.
Di Martino M; Vitale A; Ferraro D; Maniscalco M; Pisaniello D; Arenga G; Falaschi F; Terrone A; Iacomino A; Galeota Lanza A; Esposito C; Cillo U; Vennarecci G
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291885
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma.
Sposito C; Citterio D; Virdis M; Battiston C; Droz Dit Busset M; Flores M; Mazzaferro V
World J Gastroenterol; 2022 Sep; 28(34):4929-4942. PubMed ID: 36160651
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in hepatocellular carcinoma - should we perform downstaging?
Filipec Kanižaj T; Dinjar Kujundžić P; Ostojić A; Mijić M; Sertić Milić H; Mijić A; Mateljak M; Martinčević D; Radetić E; Vidjak V; Kocman B; Mikolašević I
Croat Med J; 2022 Aug; 63(4):317-325. PubMed ID: 36046928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
